rethinkPeptides Search
Menu
Study breakdown

Bladder Immune Cells Can Be Trained to Better Fight Recurrent UTIs

Animal StudyLow evidence
The takeaway

Bladder-resident ILC3 immune cells develop trained immunity after E. coli exposure, enhancing mucosal defense against recurrent urinary tract infections.

Trained immunity in bladder ILC3s

First demonstration that bladder-resident innate lymphoid cells can develop immune memory to better fight recurring urinary tract infections

What the researchers found

Bladder-resident ILC3s develop trained immunity following uropathogenic E. coli exposure, enhancing their ability to defend against recurrent UTIs.

Why it matters

Recurrent UTIs affect millions and are increasingly treated with antibiotics that drive resistance. Harnessing trained immunity in bladder immune cells could provide a new antibiotic-free prevention strategy.

The numbers in context

ILC3 counts compared between UTI patients and healthy controls. Recurrent UTI mouse model with primary and secondary E. coli inoculation. Adoptive transfer of naive vs UPEC-trained ILC3s.

How the study worked

Preclinical study investigating ILC3 trained immunity induction and functional significance in mucosal defense against uropathogenic E. coli in a bladder model.

Who was studied

UTI patients (tissue samples) and recurrent UTI mouse model

What this study cannot tell us

Preclinical study — trained immunity in bladder ILC3s has not been demonstrated in humans. The mechanisms may differ between species.

How to read the evidence

Preclinical study providing novel mechanistic insight. Human applicability needs to be confirmed through translational research.

When this study was published

Published in 2025, representing a novel finding in mucosal trained immunity.

The bigger picture

Trained immunity — previously studied mainly in blood immune cells — is now shown to function at mucosal surfaces like the bladder. This expands our understanding of how the body can build innate defenses at infection-prone sites.

Questions still open

  • Can bladder ILC3 trained immunity be therapeutically enhanced to prevent rUTIs in patients?
  • How long does the trained immunity persist in bladder-resident ILC3s?

Common questions

What is trained immunity?
Trained immunity is a form of immune memory in the innate immune system. Unlike adaptive immunity (which creates specific antibodies), trained immunity reprograms innate immune cells to respond more vigorously to future infections, regardless of the specific pathogen.
Could this help prevent recurring UTIs without antibiotics?
Potentially. If scientists can find ways to boost or trigger trained immunity in bladder ILC3 cells, it could provide a new antibiotic-free approach to preventing recurrent UTIs, reducing both antibiotic use and resistance.

Read the original research

Trained Immunity in Bladder ILC3s Enhances Mucosal Defense Against Recurrent Urinary Tract Infections.

Biomedicines, 14(1)

Citation

Pei, Qiaoqiao; Liu, Jiaqi; Tang, Ziwen; Tan, Jiaqing; Han, Xu; Hu, Xinrong; Liang, Zhou; Li, Feng; Zhu, Changjian; Lin, Ruoni; Zheng, Ruilin; Shen, Jiani; Liu, Qinghua; Mao, Haiping; Wu, Kefei; Chen, Wei; Zhou, Yi. (2025). Trained Immunity in Bladder ILC3s Enhances Mucosal Defense Against Recurrent Urinary Tract Infections.. Biomedicines, 14(1). https://doi.org/10.3390/biomedicines14010078